These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 24051432)
1. A DNA vaccine targeting p42.3 induces protective antitumor immunity via eliciting cytotoxic CD8+T lymphocytes in a murine melanoma model. Liu H; Geng S; Feng C; Xie X; Wu B; Chen X; Zou Q; Wang S; Cui J; Xing R; Li W; Lu Y; Wang B Hum Vaccin Immunother; 2013 Oct; 9(10):2196-202. PubMed ID: 24051432 [TBL] [Abstract][Full Text] [Related]
2. A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination. Gálvez-Cancino F; Roco J; Rojas-Colonelli N; Flores C; Murgas P; Cruz-Gómez S; Oyarce C; Varas-Godoy M; Sauma D; Lladser A Vaccine; 2017 Jul; 35(33):4148-4154. PubMed ID: 28666759 [TBL] [Abstract][Full Text] [Related]
3. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice. Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311 [TBL] [Abstract][Full Text] [Related]
4. Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. Best SR; Peng S; Juang CM; Hung CF; Hannaman D; Saunders JR; Wu TC; Pai SI Vaccine; 2009 Sep; 27(40):5450-9. PubMed ID: 19622402 [TBL] [Abstract][Full Text] [Related]
5. Heparanase DNA vaccine delivered by electroporation induces humoral immunity and cytoimmunity in animal models. Fu J; Zhao B; Dong Z; Sun Y; Luan H; Shen X; Gao X; Gong F; Li S; Song H Vaccine; 2012 Mar; 30(12):2187-96. PubMed ID: 22240343 [TBL] [Abstract][Full Text] [Related]
6. In vivo plasmid electroporation induces tumor antigen-specific CD8+ T-cell responses and delays tumor growth in a syngeneic mouse melanoma model. Kalat M; Küpcü Z; Schüller S; Zalusky D; Zehetner M; Paster W; Schweighoffer T Cancer Res; 2002 Oct; 62(19):5489-94. PubMed ID: 12359758 [TBL] [Abstract][Full Text] [Related]
7. Procyanidin, a kind of biological flavonoid, induces protective anti-tumor immunity and protects mice from lethal B16F10 challenge. Zhang L; Wang S; Liu Z; Zhang L; Wang S; Wang B Int Immunopharmacol; 2017 Jun; 47():251-258. PubMed ID: 28445856 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells. Baghban Rahimi S; Mohebbi A; Vakilzadeh G; Biglari P; Razeghi Jahromi S; Mohebi SR; Shirian S; Gorji A; Ghaemi A Arch Virol; 2018 Mar; 163(3):587-597. PubMed ID: 29149434 [TBL] [Abstract][Full Text] [Related]
9. Enhancing therapy of B16F10 melanoma efficacy through tumor vaccine expressing GPI-anchored IL-21 and secreting GM-CSF in mouse model. Zhao F; Dou J; He XF; Wang J; Chu L; Hu W; Yu F; Hu K; Wu Y; Gu N Vaccine; 2010 Apr; 28(16):2846-52. PubMed ID: 20153795 [TBL] [Abstract][Full Text] [Related]
10. Immunological protection against HPV16 E7-expressing human esophageal cancer cell challenge by a novel HPV16-E6/E7 fusion protein based-vaccine in a Hu-PBL-SCID mouse model. Lu Y; Zhang Z; Liu Q; Liu B; Song X; Wang M; Zhao X; Zhao Q Biol Pharm Bull; 2007 Jan; 30(1):150-6. PubMed ID: 17202676 [TBL] [Abstract][Full Text] [Related]
11. Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma. Lladser A; Ljungberg K; Tufvesson H; Tazzari M; Roos AK; Quest AF; Kiessling R Cancer Immunol Immunother; 2010 Jan; 59(1):81-92. PubMed ID: 19526360 [TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of melanoma: a dichotomy in the requirement for IFN-gamma in vaccine-induced antitumor immunity versus adoptive immunotherapy. Winter H; Hu HM; McClain K; Urba WJ; Fox BA J Immunol; 2001 Jun; 166(12):7370-80. PubMed ID: 11390488 [TBL] [Abstract][Full Text] [Related]
13. Potent systemic antitumor immunity induced by vaccination with chemotactic-prostate tumor associated antigen gene-modified tumor cell and blockade of B7-H1. Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S J Clin Immunol; 2007 Jan; 27(1):117-30. PubMed ID: 17180470 [TBL] [Abstract][Full Text] [Related]
14. Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53. Soong RS; Trieu J; Lee SY; He L; Tsai YC; Wu TC; Hung CF PLoS One; 2013; 8(2):e56912. PubMed ID: 23457640 [TBL] [Abstract][Full Text] [Related]
15. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. Buchan S; Grønevik E; Mathiesen I; King CA; Stevenson FK; Rice J J Immunol; 2005 May; 174(10):6292-8. PubMed ID: 15879128 [TBL] [Abstract][Full Text] [Related]
16. Treatment with mANT2 shRNA enhances antitumor therapeutic effects induced by MUC1 DNA vaccination. Choi Y; Jeon YH; Jang JY; Chung JK; Kim CW Mol Ther; 2011 May; 19(5):979-89. PubMed ID: 21063392 [TBL] [Abstract][Full Text] [Related]
17. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen. Rice J; Buchan S; Stevenson FK J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189 [TBL] [Abstract][Full Text] [Related]
18. Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression. Mohebbi A; Ebrahimzadeh MS; Baghban Rahimi S; Saeidi M; Tabarraei A; Mohebbi SR; Shirian S; Gorji A; Ghaemi A Virus Res; 2019 Feb; 261():72-80. PubMed ID: 30599161 [TBL] [Abstract][Full Text] [Related]
19. Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-beta. Jia ZC; Zou LY; Ni B; Wan Y; Zhou W; Lv YB; Geng M; Wu YZ Cancer Immunol Immunother; 2005 May; 54(5):446-52. PubMed ID: 15750831 [TBL] [Abstract][Full Text] [Related]
20. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D. Diniz MO; Lasaro MO; Ertl HC; Ferreira LC Clin Vaccine Immunol; 2010 Oct; 17(10):1576-83. PubMed ID: 20739505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]